Numnuts founder Robin Smith holds a Numnuts applicator.
THE Therapeutic Goods Administration has supported broader access to the lamb and calf pain relief products lidocaine and oral transmucosal meloxicam, in the process rejecting the appeal arguments of the Australian Veterinary Association.
However, the AVA intends to continue its fight to return the formulations – marketed respectively as NumOcaine and Ilium Buccalgesic OTM by Troy Laboratories — for use only under veterinary prescription.
NumOcaine is administered from a tamper-resistant bottle as injectable lidocaine as part…
